Wells Trecaso Financial Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-500
Closed -$100 90
2022
Q4
$100 Buy
+500
New +$48.2K ﹤0.01% 87
2022
Q2
Sell
-500
Closed -$1K 81
2022
Q1
$1K Sell
500
-1,200
-71% -$126K ﹤0.01% 93
2021
Q4
$19K Hold
1,700
0.01% 90
2021
Q3
$3K Hold
1,700
﹤0.01% 91
2021
Q2
$3K Hold
1,700
﹤0.01% 90
2021
Q1
$2K Hold
1,700
﹤0.01% 83
2020
Q4
$2K Buy
+1,700
New +$111K ﹤0.01% 82
2020
Q3
Sell
-1,000
Closed -$1K 71
2020
Q2
$1K Buy
+1,000
New +$63K ﹤0.01% 79

Other funds holding CVS

Wells Trecaso Financial Group's CVS Position: Q1 2023 in Review

Wells Trecaso Financial Group sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,367 shares — an estimated $221K sold.

Wells Trecaso Financial Group first reported a position in CVS in Q2 2020 and held it in 10 quarters. The position peaked at $358K in Q4 2021. 2,269 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Wells Trecaso Financial Group reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Wells Trecaso Financial Group sold 2,367 CVS Health shares in Q1 2023, an estimated $221K.
  • Wells Trecaso Financial Group first reported a position in CVS Health in Q2 2020 and held it in 10 quarters.
  • Wells Trecaso Financial Group's CVS Health position peaked at $358K in Q4 2021.
  • 2,269 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Wells Trecaso Financial Group's 13F filing for Q1 2023, filed 20 Apr 2023.